Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 24;24(5):169.
doi: 10.1007/s10142-024-01454-4.

Programmed cell death and melatonin: A comprehensive review

Affiliations
Review

Programmed cell death and melatonin: A comprehensive review

Mahdi Rafiyian et al. Funct Integr Genomics. .

Abstract

Melatonin (MLT), a main product of pineal gland, recently has attracted the attention of scientists due to its benefits in various diseases and also regulation of cellular homeostasis. Its receptor scares widely distributed indicating that it influences numerous organs. Programmed cell death (PCD), of which there several types, is a regulated by highly conserved mechanisms and important for development and function of different organs. Enhancement or inhibition of PCDs could be a useful technique for treatment of different diseases and MLT, due to its direct effects on these pathways, is a good candidate for this strategy. Many studies investigated the role of MLT on PCDs in different diseases and in this review, we summarized some of the most significant studies in this field to provide a better insight into the mechanisms of modulation of PCD by MLT modulation.

Keywords: Apoptosis; Autophagy; Cell death; Ferroptosis; Melatonin.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Acuña-Castroviejo D, Escames G, Venegas C, Díaz-Casado ME, Lima-Cabello E, López LC et al (2014) Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci 71(16):2997–3025 - PubMed - PMC
    1. Andersen LPH, Gögenur I, Rosenberg J, Reiter RJ (2016) The safety of melatonin in humans. Clin Drug Investig 36:169–175 - PubMed
    1. Anghel L, Baroiu L, Popazu CR, Pătraș D, Fotea S, Nechifor A et al (2022) Benefits and adverse events of melatonin use in the elderly. Experimental Therapeutic Med 23(3):1–8
    1. Arangino S, Cagnacci A, Angiolucci M, Vacca AM, Longu G, Volpe A et al (1999) Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol 83(9):1417–1419 - PubMed
    1. Arendt J (2005) Melatonin: characteristics, concerns, and prospects. J Biol Rhythms 20(4):291–303 - PubMed

LinkOut - more resources